Your browser doesn't support javascript.
loading
The update interpretation of 2020 EAU prostate cancer guideline(Part Ⅴ) / 中华泌尿外科杂志
Chinese Journal of Urology ; (12): 412-414, 2020.
Article in Chinese | WPRIM | ID: wpr-869680
ABSTRACT
EAU Guideline office updated the 2020 version of prostate cancer guideline based on novel clinical evidence. In the section of metastatic hormone sensitive prostate cancer (mHSPC), the 2020 EAU guideline introduced and strongly recommended the use of second-generation androgen receptor antagonists in combination with androgen deprivation therapy (ADT), the recommendation level of prostate radiotherapy combined with ADT to low-volume patients changed from weak to strong, and the intermittent ADT is no longer included in the recommendation.
Full text: Available Index: WPRIM (Western Pacific) Type of study: Practice guideline Language: Chinese Journal: Chinese Journal of Urology Year: 2020 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Practice guideline Language: Chinese Journal: Chinese Journal of Urology Year: 2020 Type: Article